Tumorigenic lung tumorospheres exhibit stem-like features with significantly increased expression of CD133 and ABCG2

被引:15
|
作者
Zhao, Wensi [1 ,2 ]
Luo, Yi [1 ]
Li, Boyi [1 ,2 ]
Zhang, Tao [1 ,3 ]
机构
[1] Chongqing Med Univ, Dept Oncol, Affiliated Hosp 1, 1 Youyi Rd, Chongqing 400016, Peoples R China
[2] Chongqing Med Univ, Chongqing Key Lab Mol Oncol & Epigenet, Chongqing 400016, Peoples R China
[3] Chongqing Med Univ, Radiol & Oncol Lab, Chongqing 400016, Peoples R China
基金
中国国家自然科学基金;
关键词
cancer stem cells; tumorospheres; lung cancer; CD133; breast cancer resistance protein; tumorigenicity; CELL MARKERS; SOLID TUMORS; CANCER; IDENTIFICATION; RESISTANCE; CULTURE;
D O I
10.3892/mmr.2016.5524
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Accumulating evidence supports the existence of cancer stem cells (CSCs) in human tumors, and the successful certification of CSCs may lead to the identification of therapeutic targets, which are more effective for the treatment of cancer. The use of spherical cancer models has increased in popularity in cancer stem cell investigations. Tumorospheres, which are used as a model of CSCs and are established in serum-free medium supplemented with growth factors under non-adherent conditions, are one of the most commonly used cancer spherical models and are a valuable method for enriching the CSC fraction. To investigate whether this model is applicable in lung cancer (LC), the identification of lung CSCs and their capacities is essential. In the present study, lung CSCs were enriched by sphere-forming culturing and their stem-like properties were assessed. The results indicated that the lung tumorospheres had enhanced proliferation, clonality, invasion and cisplatin-resistance, and showed significantly increased expression levels of CD133 and breast cancer resistance protein (ABCG2). These results, together with findings previously reported in literature, indicated that the sphere-forming culturing of LC cells induced the enrichment of CSCs and that the tumorospheres exhibited stem cell characteristics. In addition, the higher expression levels of CD133 and ABCG2 in the tumorospheres may provide a rationale for therapeutic targets for LC.
引用
收藏
页码:2598 / 2606
页数:9
相关论文
共 50 条
  • [1] Comparison of CD133 and ABCG2 Expression in Cancer Stem Cells
    Kim, Ja-Young
    Ahn, Eun-Kyung
    Park, Seun-Ja
    Kim, Young-Ho
    Leem, Sun-Hee
    Heo, Jeonghoon
    [J]. TISSUE ENGINEERING AND REGENERATIVE MEDICINE, 2011, 8 (05) : 489 - 494
  • [2] Expression and significance of CD133 and ABCG2 in endometriosis
    Liu, S.
    Zhou, J.
    Wen, J.
    [J]. CLINICAL AND EXPERIMENTAL OBSTETRICS & GYNECOLOGY, 2015, 42 (06): : 771 - 775
  • [3] The effect of hericium polysaccharides combined with aspirin on the expression of CD133 and ABCG2 in lung cancer
    Lu, Zhansheng
    Liu, Bo
    Zhang, Qinbing
    Luo, Meng
    Sun, Yongpan
    [J]. TRANSLATIONAL CANCER RESEARCH, 2019, 8 (03) : 909 - 916
  • [4] Expression of nestin, CD133 and ABCG2 in relation to the clinical outcome in pediatric sarcomas
    Zambo, Iva
    Hermanova, Marketa
    Zapletalova, Danica
    Skoda, Jan
    Mudry, Peter
    Kyr, Michal
    Zitterbart, Karel
    Sterba, Jaroslav
    Veselska, Renata
    [J]. CANCER BIOMARKERS, 2016, 17 (01) : 107 - 116
  • [5] Prognostic value of the stem cell markers CD133 and ABCG2 expression in esophageal squamous cell carcinoma
    Hang, D.
    Dong, H. -C.
    Ning, T.
    Dong, B.
    Hou, D. -L.
    Xu, W. -G.
    [J]. DISEASES OF THE ESOPHAGUS, 2012, 25 (07) : 638 - 644
  • [6] Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment
    Bertolini, Giulia
    Roz, Luca
    Perego, Paola
    Tortoreto, Monica
    Fontanella, Enrico
    Gatti, Laura
    Pratesi, Graziella
    Fabbri, Alessandra
    Andriani, Francesca
    Tinelli, Stella
    Roz, Elena
    Caserini, Roberto
    Lo Vullo, Salvatore
    Camerini, Tiziana
    Mariani, Luigi
    Delia, Domenico
    Calabro, Elisa
    Pastorino, Ugo
    Sozzi, Gabriella
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (38) : 16281 - 16286
  • [7] Expressions of ABCG2, CD133, and Podoplanin in Salivary Adenoid Cystic Carcinoma
    Li, Wuwei
    Tamamura, Ryo
    Wang, Bo
    Liu, Qigui
    Liu, Han
    Liu, Tingjiao
    Katase, Naoki
    Xiao, Jing
    Nagatsuka, Hitoshi
    [J]. BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [8] Detection of CD133, Bmi-1, and ABCG2 in ameloblastic tumors
    Kumamoto, Hiroyuki
    Ohki, Kousuke
    [J]. JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2010, 39 (01) : 87 - 93
  • [9] Highly tumorigenic lung cancer CD133-positive cells display stem-like features and are spared by cisplatin treatment
    Bertolini, Giulia
    Roz, Luca
    Perego, Paola
    Pratesi, Graziella
    Andriani, Francesca
    Roz, Elena
    Lo Vullo, Salvatore
    Delia, Domenico
    Pastorino, Ugo
    Sozzi, Gabriella
    [J]. CANCER RESEARCH, 2009, 69
  • [10] Melanoma contains CD133 and ABCG2 positive cells with enhanced tumourigenic potential
    Monzani, Elena
    Facchetti, Floriana
    Galmozzi, Enrico
    Corsini, Elena
    Benetti, Anna
    Cavazzin, Chiara
    Gritti, Angela
    Piccinini, Andrea
    Porro, Danilo
    Santinami, Mario
    Invernici, Gloria
    Parati, Eugenio
    Alessandri, Giulio
    La Porta, Caterina A. M.
    [J]. EUROPEAN JOURNAL OF CANCER, 2007, 43 (05) : 935 - 946